quorthton, yes it is the same old story. Ignorant little shorts like you come to a message board like SNTA after a minor (and in my view) overblown attack on a company after the 2nd in the NSCLC interim data came in. You post repeated mocking attacks against longs despite the fact you know nothing about the drug or about cancer.
A quote from my favorite SCI-FI show Babylon 5 is very apt with regards to you and your ilk. Arrogance and stupidity in the same package, how efficient of you. I told you that one could see by looking at the interim NSCLC data that women did remarkably well on Ganetespib + docetaxal, and that boded very well for the Enchant Breast cancer trial, which is why I bought back SNTA at $4.60. I enjoy seeing shorts like you and this holywallst clown get fried. Keep shorting things about which you know nothing.
my arent you cranky , seems all these institutional investors such as the baker brothers must all be playing the fool according to your account? We will see who's knockin on the devils door in 6 months